Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-29 in Papulopustular Rosacea
NCT03340961Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Oct 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minocycline in papulopustular rosacea (4 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoints: Investigator Global Assessment at 16 weeks and Total Inflammatory Lesion Count Reduction at 16 weeks. Started Oct 2017; status: completed.
02
Drugs
minocycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT03340961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340961.